Edition:
United Kingdom

Axsome Therapeutics Inc (AXSM.OQ)

AXSM.OQ on NASDAQ Stock Exchange Global Market

7.94USD
15 Jan 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$7.94
Open
$7.52
Day's High
$8.20
Day's Low
$7.01
Volume
516,694
Avg. Vol
259,783
52-wk High
$9.15
52-wk Low
$1.94

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.315
Jun '18 0.00 -0.321
Mar '18 0.00 -0.188
FY 2017 Dec '17 0.00 -0.306
Sep '17 0.00 -0.272
Jun '17 0.00 -0.300
Mar '17 0.00 -0.409
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-19 3 15.00 25.00 0.00 32.50
Earnings (per share)
Quarter Ending Mar-19 2 -0.28 -0.26 -0.30 --
Quarter Ending Jun-19 2 -0.26 -0.24 -0.28 --
Year Ending Dec-19 4 -0.61 -0.15 -1.16 -1.59
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 34.38
P/E High - Last 5 Yrs. -- 148.01 46.19
P/E Low - Last 5 Yrs. -- 47.79 24.58
Beta -- 1.08 0.91
Price to Sales (TTM) -- 49.51 6.26
Price to Book (MRQ) 6.43 10.16 5.20
Price to Tangible Book (MRQ) 6.43 13.82 6.73
Price to Cash Flow (TTM) -- 52.80 24.17
% Owned Institutions 26.43 3.75 1.75

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.44
Dividend Yield - 5 Year Avg -- 0.09 1.46
Dividend 5 Year Growth Rate -- 0.79 4.93
Payout Ratio(TTM) -- 7.04 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 129.91 8.17
Sales (TTM) vs TTM 1 Yr. Ago -- 47.85 6.48
Sales - 5 Yr. Growth Rate -- 22.76 10.45
EPS (MRQ) vs Qtr. 1 Yr. Ago 15.60 75.87 23.23
EPS (TTM) vs TTM 1 Yr. Ago -26.98 -- --
EPS - 5 Yr. Growth Rate -- 12.03 10.50
Capital Spending - 5 Yr. Growth Rate -- 9.25 14.62

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.30
Current Ratio (MRQ) 4.73 3.43 3.12
LT Debt to Equity (MRQ) 35.50 18.73 11.47
Total Debt to Equity (MRQ) 43.83 31.43 16.03
Interest Coverage (TTM) -62.51 -43.27 30.53

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.29 54.45
Gross Margin - 5 Yr. Avg. -- 60.55 52.36
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.00 13.10
Operating Margin (TTM) -- -184.40 6.05
Operating Margin - 5 Yr. Avg. -- -126.43 8.39
Pre-Tax Margin (TTM) -- -175.18 7.01
Pre-Tax Margin - 5 Yr. Avg. -- -132.58 8.67
Net Profit Margin (TTM) -- -181.91 3.11
Net Profit Margin - 5 Yr. Avg. -- -136.98 4.86
Effective Tax Rate (TTM) -- 21.48 23.27
Effective Tax Rate - 5 Yr. Avg. -- 15.57 23.83

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 7,650,987 873,304,761
Net Income/Employee (TTM) -1,345,586 652,634 103,509,273
Receivable Turnover (TTM) -- 6.25 5.80
Inventory Turnover (TTM) -- 1.89 3.57
Asset Turnover (TTM) 0.00 0.32 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -74.90 6.45 11.45
Return on Assets - 5 Yr. Avg. -- 5.52 12.50
Return on Investment (TTM) -90.07 8.99 14.96
Return on Investment - 5 Yr. Avg. -- 6.86 16.23
Return on Equity (TTM) -102.68 10.14 16.53
Return on Equity - 5 Yr. Avg. -- 8.39 17.36
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -38.95 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Axsome Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 29.17 24.71 99 98
13 Week 12.73 7.24 99 94
26 Week 67.57 54.83 99 98
52 Week -28.82 -39.67 61 68
YTD -8.15 -19.34 75 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 11.91%
# of Holders: 41
Total Shares Held: 3,549,538
3 Mo. Net Change: 783
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 1
# Reduced Positions: 0
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.